Crosstalk between triple negative breast cancer and microenvironment

Karly Smrekar1, Artem Belyakov1, Kideok Jin1

  • 1Department of Pharmaceutical Sciences, Albany College of Pharmacy and Health Science, Albany, NY 12208, USA.

Oncotarget
|March 31, 2023
PubMed

Insights

Triple-negative breast cancer (TNBC) remains challenging to treat, with limited survival improvements. This review explores TNBC mechanisms and therapeutic strategies, focusing on the tumor microenvironment (TME) to identify effective treatments.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • Triple-negative breast cancer (TNBC) lacks targeted therapies, significantly impacting patient survival rates.
  • The tumor microenvironment (TME) is a critical factor in TNBC development and progression.
  • Current treatment advancements have not substantially improved overall survival for TNBC patients.

Purpose of the Study:

  • To review recent progress in understanding TNBC biology.
  • To define the mechanisms underlying current and emerging TNBC therapies.
  • To identify potential therapeutic strategies to overcome TNBC challenges.

Main Methods:

  • Literature review of preclinical and clinical studies on TNBC.
  • Analysis of research on the role of the tumor microenvironment in TNBC.
  • Synthesis of information on therapeutic strategies and their mechanisms.

Main Results:

  • TNBC remains a significant clinical challenge with limited therapeutic options.
  • The TME critically influences TNBC progression and treatment response.
  • Understanding TNBC mechanisms is crucial for developing effective therapies.

Conclusions:

  • Effective therapies for TNBC are urgently needed.
  • Targeting the TME presents a promising strategy for TNBC treatment.
  • Further research into TNBC mechanisms can guide the development of novel therapeutic approaches.